AAP
Aristotle Atlantic Partners Portfolio holdings
AUM
$3.29B
This Quarter Return
+5.83%
1 Year Return
+24.5%
3 Year Return
+129.49%
5 Year Return
+188.87%
10 Year Return
–
AUM
$288M
AUM Growth
+$288M
(+4.1%)
Cap. Flow
-$1.92M
Cap. Flow
% of AUM
-0.67%
Top 10 Holdings %
Top 10 Hldgs %
61.3%
Holding
95
New
4
Increased
57
Reduced
7
Closed
12
Top Buys
| 1 |
Bio-Techne
TECH
|
$2.53M |
| 2 |
Microsoft
MSFT
|
$1.84M |
| 3 |
Global Payments
GPN
|
$1.76M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$1.36M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$987K |
Top Sells
| 1 |
MON
Monsanto Co
MON
|
$7.03M |
| 2 |
SHPG
Shire pic
SHPG
|
$2.89M |
| 3 |
Gilead Sciences
GILD
|
$2.41M |
| 4 |
Murphy Oil
MUR
|
$1.65M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$1.54M |
Sector Composition
| 1 | Healthcare | 33.61% |
| 2 | Energy | 17.8% |
| 3 | Industrials | 17.78% |
| 4 | Technology | 10.38% |
| 5 | Financials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$210B
| $42.2M | 14.63% |
695,010
| – | – |
|
2
Exxon Mobil
XOM
$487B
| $27.3M | 9.46% |
329,696
-4,350
| -1% | -$360K |
|
3
Union Pacific
UNP
$133B
| $22.7M | 7.86% |
160,000
| – | – |
|
|
4
Murphy Oil
MUR
$3.55B
| $18.5M | 6.42% |
548,637
-49,000
| -8% | -$1.65M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $14M | 4.86% |
176,392
+2,731
| +2% | +$217K |
|
6
Roper Technologies
ROP
$56.6B
| $12.3M | 4.28% |
44,697
+526
| +1% | +$145K |
|
7
JPMorgan Chase
JPM
$829B
| $11M | 3.83% |
105,995
+2,845
| +3% | +$296K |
|
8
Thermo Fisher Scientific
TMO
$186B
| $11M | 3.83% |
53,260
+736
| +1% | +$152K |
|
9
Ametek
AME
$42.7B
| $10.5M | 3.64% |
145,549
+1,872
| +1% | +$135K |
|
10
PotlatchDeltic
PCH
$3.25B
| $7.22M | 2.5% |
142,065
| – | – |
|
|
11
Microsoft
MSFT
$3.77T
| $6.97M | 2.42% |
70,665
+18,717
| +36% | +$1.84M |
|
12
Boeing
BA
$177B
| $6.22M | 2.16% |
18,529
+1,075
| +6% | +$361K |
|
13
American Tower
AMT
$95.5B
| $5.77M | 2% |
40,000
| – | – |
|
14
Parker-Hannifin
PH
$96.2B
| $5.46M | 1.89% |
35,024
+460
| +1% | +$71.7K |
|
|
15
Gilead Sciences
GILD
$140B
| $4.43M | 1.53% |
62,500
-34,000
| -35% | -$2.41M |
|
|
16
Bio-Techne
TECH
$8.5B
| $4.01M | 1.39% |
27,110
+17,110
| +171% | +$2.53M |
|
17
Apple
AAPL
$3.45T
| $3.8M | 1.32% |
20,509
+1,924
| +10% | +$356K |
|
18
Cooper Companies
COO
$13.4B
| $3.77M | 1.31% |
16,000
| – | – |
|
19
EOG Resources
EOG
$68.2B
| $3.46M | 1.2% |
27,778
+845
| +3% | +$105K |
|
|
PF
20
DELISTED
Pinnacle Foods, Inc.
PF
| $3.41M | 1.18% |
52,371
+2,390
| +5% | +$155K |
|
21
Murphy USA
MUSA
$7.26B
| $3.22M | 1.12% |
43,413
-10,145
| -19% | -$753K |
|
|
22
Global Payments
GPN
$21.5B
| $3.2M | 1.11% |
28,750
+15,750
| +121% | +$1.76M |
|
|
AGN
23
DELISTED
Allergan plc
AGN
| $3.02M | 1.05% |
18,155
+1,205
| +7% | +$201K |
|
24
Idexx Laboratories
IDXX
$51.8B
| $2.95M | 1.02% |
13,526
| – | – |
|
25
Align Technology
ALGN
$10.3B
| $2.74M | 0.95% |
8,022
-1,099
| -12% | -$376K |
|